Nanoparticulate Alternatives for Drug Delivery
ACS Nano2010Vol. 4(9), pp. 4967–4970
Citations Over TimeTop 10% of 2010 papers
Abstract
The ability to apply nanomaterials as targeted delivery agents for drugs and other therapeutics holds promise for a wide variety of diseases, including many types of cancer. A nanodelivery vehicle must demonstrate in vivo efficacy, diminished or no toxicity, stability, improved pharmacokinetics, and controlled-release kinetics. In this issue, Lee et al. construct polymer nanobins that fulfill these requirements and demonstrate effective delivery of doxorubicin in vivo to breast cancer cells. This Perspective explores the outlook for these nanobins as well as other technologies in this field and the challenges that lie ahead.
Related Papers
- → A comparison of in vivo and in vitro methods for determining availability of iron from meals(1981)109 cited
- → Studies on pharmacokinetics of sulfonated aluminum phthalocyanine in a transplantable mouse tumor by in vivo fluorescence(1993)8 cited
- Study and Two Types of Typical Usage of DataGrid Web Server Control(2005)
- Using DataGrid Control to Realize DataBase of Querying in VB6.0(2000)
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)